Best of the Brokers for 24 November 2014

To appear in Best of the Brokers, email your research to

Numis reiterated its “buy” rating for Bodycote, following third-quarter results that showed organic growth had declined since the first half of the year, “reflecting weaker European markets over the summer shutdowns and continued softness in aerospace”. Target price is 720p.

Shore Capital reiterated its “buy” rating off the back of the firm’s preliminary results, published earlier this month. The broker said the numbers were “solid” adding that despite potential challenges ahead, especially in UK farming, it expected Carr’s to deliver another year of progress.

Cantor Fitzgerald reiterated its “buy” rating. The broker noted a “muted” market reaction to the news last week that GFM’s output had been hit by a four-week over-run on the plant expansion work, which it said suggested that the market was focused on the firm’s long-term production.